Q9NXA8 (SIR5_HUMAN) Homo sapiens (Human)
NAD-dependent protein deacylase sirtuin-5, mitochondrial UniProtKBInterProSTRINGInteractive Modelling
310 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4);
1 identical sequence: Homo sapiens: A0A024R012
It is possible new templates exist for this target since these models were created.
Available Structures
18 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Sirt5 is an NAD-dependent protein lysine demalonylase and desuccinylase |
Heteromer P68431; | 1×ZN; 1×NAD; | ||||
| Assess | ||||||
| histone lysine desuccinylase Sirt5 in complex with succinyl peptide H2BK120 |
Heteromer P62807; | 1×ZN; 1×CL; 1×GOL; | ||||
| Assess | ||||||
| Sirt5 is an NAD-dependent protein lysine demalonylase and desuccinylase |
Heteromer P68431; | 1×ZN; 1×NHE; | ||||
| Assess | ||||||
| The bicyclic intermediate structure provides insights into the desuccinylation mechanism of SIRT5 |
Heteromer P68431; | 1×ZN; | ||||
| Assess | ||||||
| The bicyclic intermediate structure provides insights into the desuccinylation mechanism of SIRT5 |
Heteromer P68431; | 1×ZN; 1×CGK; | ||||
| Assess | ||||||
| histone lysine desuccinylase Sirt5 in complex with succinyl peptide H2AK95 |
Heteromer P04908; | 1×ZN; | ||||
| Assess | ||||||
| histone lysine desuccinylase Sirt5 in complex with succinyl peptide H3K122 |
Heteromer Q71DI3; | 1×ZN; 2×GOL; | ||||
| Assess | ||||||
| histone lysine desuccinylase Sirt5 in complex with succinyl peptide H4K91 |
Heteromer P62805; | 1×ZN; | ||||
| Assess | ||||||
| Crystal Structure of Human Sirtuin Homolog 5 in Complex with Suramin | homo-2-mer | 2×ZN; 1×SVR; | ||||
| Assess | ||||||
| Human Sirt5 in complex with stalled peptidylimidate intermediate of inhibitory compound 29 | monomer | 1×ZN; 1×BV8; 5×EDO; 2×BU2; 2×DMS; | ||||
| Assess | ||||||
| Crystal structure of human Sirt5 in complex with an internally quenched fluorescent substrate GluIQF | monomer | 1×ZN; 1×NA; 1×GUA; | ||||
| Assess | ||||||
| Crystal Structure of SIRT5 in Complex with a Coumarin-Labelled Succinyl Peptide | monomer | 1×ZN; 1×MCM; | ||||
| Assess | ||||||
| Crystal structure of human Sirt5 in complex with the fluorogenic tetrapeptide substrate P13 | monomer | 1×ZN; 1×SIN; 1×ACY; 1×MCM; | ||||
| Assess | ||||||
| Crystal structure of human Sirt5 in complex with the fluorogenic tetrapeptide substrate P15 | monomer | 1×ZN; 1×SIN; 1×ACY; 1×MCM; | ||||
| Assess | ||||||
| Crystal Structure of Human Sirtuin homolog 5 | monomer | 1×ZN; 1×APR; 1×EPE; | ||||
| Assess | ||||||
| Human SIRT5 bound to Succ-IDH2 and Carba-NAD | monomer | 1×ZN; 1×CNA; | ||||
| Assess | ||||||
| Crystal structure of SIRT5 complexed with a fluorogenic small-molecule substrate SuBKA | monomer | 1×PHQ; 1×SLL; 1×MCM; 1×ZN; | ||||
| Assess | ||||||
| Crystal structure of human Sirt5 in complex with Fluor-de-Lys peptide and resveratrol | monomer | 1×ZN; | ||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6ljk.1.A | monomer | 0.90 | 1×BE2; 1×ZN; | 100.00 | ||
| Assess | ||||||
3 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 3riy.2.A | monomer | 0.86 | 1×ZN; | 95.82 | |
| Assess | ||||||
| Isoform 3 | 6aco.1.A | monomer | 0.88 | 1×ZN; | 100.00 | |
| Assess | ||||||
| Isoform 4 | 6aco.1.A | monomer | 0.88 | 1×ZN; | 100.00 | |
| Assess | ||||||